Wheat alpha-amylase inhibitor for the treatment of diabetes.

摘要

The present invention relates to a composition for the treatment of diabetes mellitus type II comprising Deobesitogen as an active ingredient. Deobesitogen is a partially purified alpha -amylase inhibitor obtained by subjecting a concentrate of the aqueous extract from wheat flour to column chromatography to remove sugar and a part of inorganic matters from the alpha -amylase inhibitor and then drying. The composition of the present invention exhibits such a remarkable effect on the treatment by administering the drug to the patient with diabetes mellitus type II that does not necessitate calorie control. <IMAGE>